एपीए उद्धरण

Wang, X., Wang, X., Hodgson, L., George, S. L., Sargent, D. J., Foster, N. R., . . . Pang, H. (2017). Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials. Oncologist.

शिकागो स्टाइल उद्धरण

Wang, Xiaofei, et al. "Validation of Progression‐Free Survival As a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials." Oncologist 2017.

एमएलए उद्धरण

Wang, Xiaofei, et al. "Validation of Progression‐Free Survival As a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials." Oncologist 2017.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.